Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/3974
DC FieldValueLanguage
dc.contributor.authorSavini, Luisaen_us
dc.contributor.authorMassarelli, Paolaen_us
dc.contributor.authorCorti, Pieroen_us
dc.contributor.authorPellerano, Cesareen_us
dc.contributor.authorBruni, Giancarloen_us
dc.contributor.authorRomeo, M. R.en_us
dc.date.accessioned2021-03-30T14:36:37Z-
dc.date.available2021-03-30T14:36:37Z-
dc.date.issued1993-
dc.identifier.issn0014-827Xen_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/3974-
dc.description4642en_US
dc.description.abstractTwo new series od 2-arylpyrazolo[4,3-c]quinolin-3-ones (6,8-difluoro- and 7,9-dichloro-derivatives) have been synthesized and tested for their ability to displace [H-3]flunitrazepam from rat brain membranes. Several compounds possess comparable and sometimes higher affinity for central benzodiazepine receptors than that of diazepam. Some selected compounds were also tested in vivo in the anti-pentylenetetrazol test; some anticovulsant activity resulted for the 6,8-difluoroderivatives only.en_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofIL FARMACOen_US
dc.titlePyrazolo[4,3-c]quinolines. Synthesis and specific inhibition of benzodiazepine receptor binding. Note IIen_US
dc.typeArticleen_US
dc.identifier.pmid8135991en_US
dc.identifier.scopus2-s2.0-0027880132en_US
dc.identifier.isiWOS:A1993MX39100006en_US
dc.relation.volume48en_US
dc.relation.issue12en_US
dc.description.firstpage1675en_US
dc.description.lastpage1686en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.